APRIA INC (APR) Stock Price, Quote, News and Overview
NASDAQ:APR - Nasdaq - Common Stock
APR Quote, Performance and Key Statistics
37.5
+0.01 (+0.03%)
The current stock price of APR is 37.5 null. In the past month the price increased by 0.43%. In the past year, price increased by 32.23%.
APR Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CI | THE CIGNA GROUP | 10.97 | 82.08B | ||
| CVS | CVS HEALTH CORP | 11.71 | 79.88B | ||
| LH | LABCORP HOLDINGS INC | 17.15 | 20.84B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.1 | 19.12B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 13.74 | 13.55B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 148.77 | 12.18B | ||
| DVA | DAVITA INC | 14.99 | 11.68B | ||
| HIMS | HIMS & HERS HEALTH INC | 112 | 10.77B | ||
| CHE | CHEMED CORP | 23.84 | 8.18B | ||
| CRVL | CORVEL CORP | 25.97 | 5.57B | ||
| OPCH | OPTION CARE HEALTH INC | 26.89 | 5.45B | ||
| GH | GUARDANT HEALTH INC | N/A | 5.30B |
Related stock screener links
About APR
Company Profile
Apria, Inc. engages in the provision of healthcare services. The company is headquartered in Indianapolis, Indiana and currently employs 6,080 full-time employees. The company went IPO on 2021-02-11. The firm offers a range of products and services for in-home care and delivery across three core service lines, which includes home respiratory therapy (including home oxygen and non-invasive ventilation (NIV) services); obstructive sleep apnea (OSA) treatment (including continuous positive airway pressure (CPAP) and bi-level positive airway pressure devices, and patient support services) and negative pressure wound therapy (NPWT). Additionally, the Company supplies a range of home medical equipment and other products and services for patients with home care needs. The company also provides a variety of clinical and administrative support services and related products and supplies. The company offers in-home delivery, set-up, and maintenance of equipment and/or supplies; monitoring therapy compliance and intervening to enhance compliance and processing claims to payors on behalf of patients.
Company Info
APRIA INC
7353 Company Drive
Indianapolis INDIANA 46237 US
CEO: Daniel J. Starck
Employees: 6080
Company Website: https://www.apria.com/
Phone: 18009909799.0
APRIA INC / APR FAQ
What is the stock price of APRIA INC today?
The current stock price of APR is 37.5 null. The price increased by 0.03% in the last trading session.
What is the ticker symbol for APRIA INC stock?
The exchange symbol of APRIA INC is APR and it is listed on the Nasdaq exchange.
On which exchange is APR stock listed?
APR stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for APRIA INC stock?
9 analysts have analysed APR and the average price target is 39.1 null. This implies a price increase of 4.27% is expected in the next year compared to the current price of 37.5. Check the APRIA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is APRIA INC worth?
APRIA INC (APR) has a market capitalization of 1.34B null. This makes APR a Small Cap stock.
How many employees does APRIA INC have?
APRIA INC (APR) currently has 6080 employees.
What are the support and resistance levels for APRIA INC (APR) stock?
APRIA INC (APR) has a support level at 37.47 and a resistance level at 37.7. Check the full technical report for a detailed analysis of APR support and resistance levels.
Is APRIA INC (APR) expected to grow?
The Revenue of APRIA INC (APR) is expected to grow by 5.14% in the next year. Check the estimates tab for more information on the APR EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy APRIA INC (APR) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of APR, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of APR, evaluating the profitability, health, valuation and growth aspects
- APRIA INC (APR) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- APRIA INC (APR) Sales and EPS estimates to see what analysts future expectations are.
- APRIA INC (APR) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- APRIA INC (APR) Insider and Institutional Ownership to learn about the owners and their transactions.
- APRIA INC (APR) Stock Chart to make your own analysis
- APRIA INC (APR) Latest news and press-releases to stay up to date.
Does APRIA INC (APR) stock pay dividends?
APR does not pay a dividend.
When does APRIA INC (APR) report earnings?
APRIA INC (APR) will report earnings on 2022-05-11.
What is the Price/Earnings (PE) ratio of APRIA INC (APR)?
The PE ratio for APRIA INC (APR) is 21.43. This is based on the reported non-GAAP earnings per share of 1.75 and the current share price of 37.5 null. Check the full fundamental report for a full analysis of the valuation metrics for APR.
APR Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to APR. When comparing the yearly performance of all stocks, APR is one of the better performing stocks in the market, outperforming 92.29% of all stocks.
APR Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to APR. While APR belongs to the best of the industry regarding profitability, there are concerns on its financial health.
APR Financial Highlights
Over the last trailing twelve months APR reported a non-GAAP Earnings per Share(EPS) of 1.75. The EPS increased by 29.97% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.66% | ||
| ROA | 8.36% | ||
| ROE | 163.17% | ||
| Debt/Equity | 8.58 |
APR Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 47% to APR. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 5.86% and a revenue growth 5.14% for APR